Massachusetts Financial Services’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-26,878
| Closed | -$198K | – | 846 |
|
2023
Q2 | $198K | Sell |
26,878
-634
| -2% | -$4.66K | ﹤0.01% | 812 |
|
2023
Q1 | $285K | Sell |
27,512
-777
| -3% | -$8.05K | ﹤0.01% | 821 |
|
2022
Q4 | $334K | Buy |
28,289
+598
| +2% | +$7.06K | ﹤0.01% | 827 |
|
2022
Q3 | $581K | Sell |
27,691
-252
| -0.9% | -$5.29K | ﹤0.01% | 807 |
|
2022
Q2 | $867K | Buy |
27,943
+140
| +0.5% | +$4.34K | ﹤0.01% | 785 |
|
2022
Q1 | $1.14M | Buy |
27,803
+285
| +1% | +$11.7K | ﹤0.01% | 790 |
|
2021
Q4 | $1.2M | Sell |
27,518
-558
| -2% | -$24.3K | ﹤0.01% | 809 |
|
2021
Q3 | $1.41M | Sell |
28,076
-369
| -1% | -$18.5K | ﹤0.01% | 809 |
|
2021
Q2 | $1.79M | Buy |
28,445
+243
| +0.9% | +$15.3K | ﹤0.01% | 792 |
|
2021
Q1 | $2.62M | Sell |
28,202
-3,347
| -11% | -$311K | ﹤0.01% | 735 |
|
2020
Q4 | $2.83M | Buy |
31,549
+6,796
| +27% | +$609K | ﹤0.01% | 703 |
|
2020
Q3 | $2.56M | Buy |
24,753
+837
| +3% | +$86.5K | ﹤0.01% | 695 |
|
2020
Q2 | $1.89M | Sell |
23,916
-612
| -2% | -$48.4K | ﹤0.01% | 691 |
|
2020
Q1 | $1.42M | Buy |
+24,528
| New | +$1.42M | ﹤0.01% | 712 |
|
2018
Q4 | – | Sell |
-31,970
| Closed | -$2.11M | – | 861 |
|
2018
Q3 | $2.11M | Sell |
31,970
-74
| -0.2% | -$4.87K | ﹤0.01% | 716 |
|
2018
Q2 | $1.62M | Buy |
32,044
+4,388
| +16% | +$222K | ﹤0.01% | 730 |
|
2018
Q1 | $1.46M | Buy |
27,656
+517
| +2% | +$27.2K | ﹤0.01% | 727 |
|
2017
Q4 | $1.26M | Buy |
27,139
+4,432
| +20% | +$206K | ﹤0.01% | 732 |
|
2017
Q3 | $918K | Buy |
+22,707
| New | +$918K | ﹤0.01% | 757 |
|
2014
Q3 | – | Sell |
-29,945
| Closed | -$673K | – | 882 |
|
2014
Q2 | $673K | Sell |
29,945
-15,095
| -34% | -$339K | ﹤0.01% | 826 |
|
2014
Q1 | $1.14M | Sell |
45,040
-3,040
| -6% | -$76.8K | ﹤0.01% | 743 |
|
2013
Q4 | $1.11M | Sell |
48,080
-3,590
| -7% | -$82.5K | ﹤0.01% | 716 |
|
2013
Q3 | $984K | Sell |
51,670
-1,890
| -4% | -$36K | ﹤0.01% | 718 |
|
2013
Q2 | $772K | Buy |
+53,560
| New | +$772K | ﹤0.01% | 737 |
|